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                TRANSCRIPTOMIC CHANGES IN THE AIRWAY DUE TO 
DIESEL ENGINE EXHAUST EXPOSURE 
EDUARD IOSIFOVICH DRIZIK 
ABSTRACT 
Introduction: Recent epidemiological studies have shown that Diesel Engine Exhaust 
(DEE) exposure is associated with lung cancer. Well recognized exposures, such as 
smoking, have long been known to cause lung cancer, and the mechanisms by which 
the disease occurs have been closely investigated. However, there is very little 
information regarding the mechanisms by which chronic DEE exposure leads to a 
disease outcome. It has also been shown that transcriptomic changes in the deeper 
portions of the airway may be detectable in the more proximal parts. The goal of this 
study was to assess transcriptomic alterations in the nasal epithelium of DEE exposed 
factory workers to better understand the physiologic effects of DEE and how chronic 
exposure may lead to disease.  
 
Methods: Nasal epithelium brushings were obtained from 41 subjects who work in a 
factory with DEE exposure, and 38 comparable control subjects who work in factories 
without DEE exposure. The median Elemental Carbon (EC) levels of exposed 
individuals was 60.7g/m3, with a range of 17.2-105.4 g/m3, while the median of EC 
levels of unexposed controls was 10.87g/m3, with a range of 9.89-12.55g/m3. RNA 
was isolated from nasal epithelial cells, and profiled for gene expression using 
Affymetrix Human Gene 1.0ST microarray chips. Linear modeling was used to detect 
  vii 
differential expression between DEE exposure and controls. Pathway enrichment in 
differentially expressed genes was assessed using EnrichR. GSEA provided 
comparisons between the genes known to be differentially expressed due to smoking, 
and the genes that were found in our data to be differentially expressed due to 
smoking or DEE. A linear modeling approach was further used to investigate the 
effects of the interaction between smoking status and DEE exposure, and boxplot 
analysis was used to explore the interaction effect. 
 
Results: We found 225 genes whose expression is associated with DEE exposure at 
FDR q < 0.25, after adjusting for smoking status. Within this set of genes, we observed 
increased expression of genes involved in the oxidative stress response, cell cycle, and 
protein modification, as well as genes associated with the AhR pathway and the Nrf2-
mediated xenobiotic metabolism response. Additionally, decreased expression of 
genes involved in transmembrane transport, such as CFTR and the solute carrier 
family genes was also found. Furthermore, we discovered 8 genes at FDR q < 0.25 that 
have altered expression due to the interaction of DEE and smoking status, suggesting 
a synergistic relationship between the effects of these exposures on some aspects of 
the physiological response. For these genes, the effects of DEE were generally more 
dramatic in never smokers.  
 
Conclusions: The transcriptomic alterations we identified may help provide insight 
into the underlying mechanisms of DEE carcinogenicity. The relationship between 
  viii 
cigarette smoke exposure and DEE exposure may provide more information about 
how chronic DEE exposure leads to lung cancer and other respiratory diseases. 
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 1 
INTRODUCTION 
 
 Air pollution is a growing concern for public health worldwide. The World Health 
Organization (WHO) estimates that as of 2012, the mortality rate due to ambient outdoor 
air pollution has reached about 3 million yearly premature deaths in both rural and urban 
communities throughout the world.1 The number is estimated to have risen to 4.2 million 
in 2015 in the State of Global Air 2017 report by the Institute for Health Metrics and 
Evaluation (IHME).2 Western Pacific and South-East Asian WHO regions have seen the 
highest rates of mortality due to ambient outdoor air pollution than any other region. It is 
estimated that 14% of the yearly deaths that result from ambient outdoor air pollution are 
due to lung cancer, with further 14% due to chronic obstructive pulmonary disease or acute 
lower respiratory infections, and the rest of the 72% are due to ischemic heart disease and 
stroke.3 Both, ambient outdoor air pollution and household air pollution contributed to 
11.6% of all global deaths in 2012, which makes it the most important environmental health 
risk.4 Furthermore, recently a direct link between air pollution and lung cancer in non-
smokers has been established.5 Thus, in 2013 WHO’s International Agency for Research 
on Cancer (IARC) officially classified outdoor air pollution as carcinogenic to human 
                                                      
1 “WHO | Ambient (outdoor) Air Quality and Health.” 
2 Institute for Health Metrics and Evaluation (IHME), Health Effects Institutes, “State 
of Global Air 2017.” 
3 “WHO | Ambient (outdoor) Air Quality and Health.” 
4 “Mortality Due To Air Pollution.” 
5 Raaschou-Nielsen et al., “Air Pollution and Lung Cancer Incidence in 17 European 
Cohorts.” 
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health.6 These findings prompt further investigations into the contributing factors to both 
indoor and outdoor air pollution, as well as their effects on human health. 
 
Diesel Engine Exhaust  
Vehicles of on-road and non-road transport, as well as heavy machinery utilized in 
industrial settings are an important source of air pollution and are responsible for 
contributing 20-30% of all emissions worldwide. Diesel powered engines are widespread 
due to their robustness, efficiency, and low operating costs, which explains their prevalence 
in the mining, commercial transport, and other industry settings. Because of their ubiquity, 
but also due to their greater efficiency in producing aerosols over gasoline engines, diesel 
engines contribute the largest portion of exhaust fumes.7, 8  
Diesel fuels are attained via an arduous process and are comprised of a complex 
mixture of chemicals. The extraction from crude oil occurs via fractional distillation at 
temperatures between 450 and 650 degrees Fahrenheit 9 . The resultant blend of 
hydrocarbons of various lengths and molecular arrangements also includes contaminants, 
such as sulfur, nitrogen, oxygen, and various metals.10 These contaminants are removed in 
further processing steps, leaving aromatic and majority aliphatic hydrocarbon compounds 
                                                      
6 IARC, “IARC: Outdoor Air Pollution A Leading Environmental Cause of Cancer 
Deaths.” 
7 Reşitoğlu, Altinişik, and Keskin, “The Pollutant Emissions from Diesel-Engine 
Vehicles and Exhaust Aftertreatment Systems.” 
8 Gentner et al., “Elucidating Secondary Organic Aerosol from Diesel and Gasoline 
Vehicles through Detailed Characterization of Organic Carbon Emissions.” 
9 “Crude Oil Distillation and the Definition of Refinery Capacity - Today in Energy - 
U.S. Energy Information Administration (EIA).” 
10 Oil in the Sea. 
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ranging between 8-21 carbon atoms to form what we know as diesel. As a fuel, diesel is 
known for its efficiency and lack of volatility, which makes it more advantageous than 
gasoline, especially in more powerful and higher capacity engines11, 12. However, though 
diesel fuels are more efficacious and safer in use compared to other fuel types derived from 
crude oil, diesel engine byproducts are complex and create new challenges, especially for 
public health. 
The use of diesel fuels directly leads to diesel engine exhaust (DEE), which is 
comprised of both gaseous and particulate phases, and may even contain traces of motor 
oil. Some of the components that make up the gaseous phase of DEE are various low-
molecular-weight hydrocarbons, carbon monoxide and dioxide, water, oxygen, various 
nitrogen oxides (NOx) and other nitrogenous compounds, as well as sulfur compounds. 
Previous research has recognized components of the gaseous hydrocarbons as various 
aldehydes, benzene, 1,3-butadiene, and both polycyclic aromatic hydrocarbons (PAHs), 
such as benzo(a)pyrene, and nitro-PAHs, which were all linked with diseases in humans.13, 
14 The health effects of DEE are complicated further with the complexity of its particulate 
phase. 
The particulate phase of DEE occurs largely due to the incomplete combustion of 
diesel and its make-up is important in understanding the health hazard that it presents. The 
                                                      
11 “Petroleum - Refining.” 
12 Gentner et al., “Elucidating Secondary Organic Aerosol from Diesel and Gasoline 
Vehicles through Detailed Characterization of Organic Carbon Emissions.” 
13 US Environmental Protection Agency, Office of Research and Development, 
National Center for Environmental Assessment, Washington Office, “US EPA Health 
Assessment Document for Diesel Engine Exhaust.” 
14 Ris, “U.S. EPA Health Assessment for Diesel Engine Exhaust.” 
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particulate phase is understood as a formulation of particulate matter (PM) of aerodynamic 
diameters below 10m, 2.5m, and 0.1m (PM10, PM2.5, PM0.1 respectively), of which the 
smallest particles make up the majority of particulate matter and are able to reach deep into 
the airways.15 Components of gaseous matter are precursors to the formation of soot, also 
known as black carbon, which makes up an important part of the particulate phase and 
gives it a distinctive black coloration. 16  Additionally, similar to the gaseous phase, 
particulate phase contains sulfur, nitrogenous oxides (NOx) and compounds, as well as 
PAHs and nitro-PAHs. Moreover, this part of DEE also includes elemental carbon, 
condensed organic carbon, and various heavy metals. 17  It is important to note that 
elemental carbon (EC) can be accurately detected at low concentrations, and has been 
shown to be a good quantitative predictor of diesel particulate matter (DPM) in 
underground mines. 18  In the US, DEE is responsible for more than two-thirds of all 
particulate matter and almost half of all NOx that are emitted from various sources of 
transportation. 19  The unravelling of the nature of DEE is vital in understanding its 
increasing importance for public health. 
                                                      
15 “Diesel Engines and Public Health.” 
16 Omidvarborna, Kumar, and Kim, “Recent Studies on Soot Modeling for Diesel 
Combustion.” 
17 US Environmental Protection Agency, Office of Research and Development, 
National Center for Environmental Assessment, Washington Office, “US EPA Health 
Assessment Document for Diesel Engine Exhaust.” 
18 Noll et al., “Relationship between Elemental Carbon, Total Carbon, and Diesel 
Particulate Matter in Several Underground Metal/non-Metal Mines.” 
19 “Diesel Engines and Public Health.” 
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Human Health Effects of Diesel Engine Exhaust Exposure 
In recent decades, health effects from DEE exposure have been a major topic of 
scientific research. The fine and ultrafine diesel exhaust particulate (DEP) matter, PM2.5 
and PM0.1 respectively, can penetrate deep into the airway20, 21, cross into the blood stream, 
and deposit inside cells22. Acute and chronic DEE exposure, especially in the workplace, 
has been associated with pathogenesis of various diseases. A 2002 health assessment of 
DEE by the EPA notes neurophysiological symptoms, such as lightheadedness and nausea, 
acute irritation to the eyes, cough and phlegm due to airway irritation, and allergy-type 
responses, such as asthma and skin irritation, as some of the consequences of short-term 
exposure. The assessment also references studies that show chronic exposure leading to 
dose-dependent inflammatory and histopathological changes in various animal models. 
However, based on the evidence from epidemiologic and scientific studies, one of the most 
substantial effects of chronic DEE exposure was identified as lung cancer. 23 
Unsurprisingly, in 2012, a year before IARC classified outdoor air pollution as a 
carcinogen, it was DEE that received this designation.24, 25 Due to the heterogeneous nature 
                                                      
20 Shimada and Matsuoka, “Analysis of Indoor PM2.5 Exposure in Asian Countries 
Using Time Use Survey.” 
21 Chalupa et al., “Ultrafine Particle Deposition in Subjects with Asthma.” 
22 Oberdörster, Oberdörster, and Oberdörster, “Nanotoxicology.” 
23 US Environmental Protection Agency, Office of Research and Development, 
National Center for Environmental Assessment, Washington Office, “US EPA Health 
Assessment Document for Diesel Engine Exhaust.” 
24 IARC, “IARC: Diesel Engine Exhaust Carcinogenic.” 
25 Benbrahim-Tallaa et al., “Carcinogenicity of Diesel-Engine and Gasoline-Engine 
Exhausts and Some Nitroarenes.” 
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of DEE, it is important to gain a good appreciation of how exactly its components actually 
lead to disease pathogenesis, especially in the lungs. 
Chronic Obstructive Pulmonary Disease 
One of the major respiratory diseases that is caused, in large part, by detrimental 
airway exposure is the Chronic Obstructive Pulmonary Disease (COPD). The Center for 
Disease Control and Prevention (CDC) classifies COPD as a disease that includes 
emphysema, chronic bronchitis, and some subtypes of asthma. When combined with other 
chronic lower respiratory diseases, COPD was the third leading cause of death in both the 
US in 201426 as well as in China in 201027, and by itself will become the third leading 
cause of death worldwide by 203028. The disease is characterized by the degradation of 
elasticity of the bronchial and alveolar parts of the airway, excessive production of mucus, 
and trapping of air that leads to obstruction of the air flow. The disease causes symptoms, 
such as wheezing, coughing, and shortness of breath.29, 30  
Although cigarettes remain the most important contributing factor to COPD onset, 
exposures to pollutants, such as DEE, also play an important role. Association studies have 
shown that DEE exposure, after adjusting for age, work years, and smoking status, is 
closely related to mortality due to COPD in railroad workers31, and is more associated with 
                                                      
26 “CDC - COPD Home Page - Chronic Obstructive Pulmonary Disease (COPD).” 
27 Yang et al., “Rapid Health Transition in China, 1990-2010.” 
28 “WHO | Burden of COPD.” 
29 Mayo Clinic Staff, “Overview - COPD - Mayo Clinic.” 
30 Pauwels et al., “Global Strategy for the Diagnosis, Management, and Prevention of 
Chronic Obstructive Pulmonary Disease.” 
31 Hart et al., “Chronic Obstructive Pulmonary Disease Mortality in Diesel-Exposed 
Railroad Workers.” 
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the disease than other types of occupational exposures32. More recently, studies in China 
have found that PM2.5, which makes up a major portion of DEE, has been closely associated 
with COPD morbidity and mortality33, 34. These findings suggest that DEE exposure may 
play an important role in causing such detrimental diseases as COPD. 
 
Asthma 
Similarly, asthma may also be caused by airway exposure to DEE, which can be 
found in occupational settings or as part of traffic-related air pollution (TRAP). Asthma 
affects 235 million people worldwide and is one of the most  prevalent childhood 
diseases35. The symptoms of this disease include wheezing, coughing, chest tightness, and 
a feeling of breathlessness, which occur due to a hyperactive inflammatory response in the 
airway36. Asthma attacks may be exacerbated by the presence of common aeroallergens, 
which include a variety of physiochemical agents. Pollutants in the air, such as NO2, as 
well as fine particulate matter (PM2.5) are both associated with asthma exacerbation37 and 
make up the particulate phase of DEE. This suggests an important role of DEE in asthma 
pathogenesis and exacerbation. 
DEE components act as aeroallergens that lead to the induction of an allergic 
inflammatory response. In asthma, the abnormal inflammation is guided by the production 
                                                      
32 Weinmann et al., “COPD and Occupational Exposures.” 
33 Song et al., “Health Burden Attributable to Ambient PM2.5 in China.” 
34 Liu et al., “Association between Exposure to Ambient Particulate Matter and 
Chronic Obstructive Pulmonary Disease.” 
35 “WHO | Asthma.” 
36 Löwhagen, “Diagnosis of Asthma – a New Approach.” 
37 Fu and Tsai, “Asthma Exacerbation in Children.” 
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of Immunoglobulin E (IgE) antibodies that are specific for the aeroallergen38, and the 
recruitment of mast cells to the airways that cause the asthma symptoms39. The prevalence 
of an IgE-mediated allergic response has been shown in individuals exposed to traffic 
pollution40 and further described to be present in the lower airway due to DEE exposure41. 
While in healthy non-smoking adults, acute nasal exposure to diesel exhaust particles 
(DEP) caused an increased production of pro-inflammatory cytokines, such as Interleukin-
4 (IL-4), as well as showed higher IgE levels, and upon an allergen challenge, a higher 
presence of T helper type 2 (TH2)-type cells42. Additionally, DEP exposure in young mice 
leads to neutrophilic influx in the lungs at high doses, and when combined with house dust 
mites showed an increase in allergen-specific IgE, various inflammatory cells, TH2 and 
TH17 cytokines, myeloid dendritic cells, activated T cells, and effector T cells, as well as 
altered the airway hyper-responsiveness of these mice and presence of mucus-producing 
goblet cells43. Thus, there is a direct link between DEE exposure and known molecular 
mechanisms that may be crucial in understanding how DEE causes the onset of asthma. 
 
                                                      
38 Reid et al., “Cross-Disciplinary Consultancy to Enhance Predictions of Asthma 
Exacerbation Risk in Boston.” 
39 Bradding, Walls, and Holgate, “The Role of the Mast Cell in the Pathophysiology of 
Asthma.” 
40 Vimercati et al., “Occupational Exposure to Urban Air Pollution and Allergic 
Diseases.” 
41 Riedl et al., “Allergic Inflammation in the Human Lower Respiratory Tract Affected 
by Exposure to Diesel Exhaust.” 
42 Diaz-Sanchez et al., “Enhanced Nasal Cytokine Production in Human Beings after 
in Vivo Challenge with Diesel Exhaust Particles.” 
43 Acciani et al., “Diesel Exhaust Particle Exposure Increases Severity of Allergic 
Asthma in Young Mice.” 
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Immunological Effects 
Unsurprisingly, there is a large body of evidence confirming that exposure to DEE 
or some of its components modulates the inflammatory response in the airway. Acute diesel 
traffic exposure has been shown to contribute to a decreased lung function that is combined 
with increased neutrophilic biomarkers in asthmatic adults44. In an in vitro study, DEP and 
its PAH components have been shown to elicit the production of IL-6 and IL-8 in BEAS-
2B human bronchial epithelial cells45. In an in vivo human study, 1hour DEE exposure has 
been shown to cause an increase in neutrophils, B lymphocytes, histamine, and fibronectin 
in bronchoalveolar lavage (BAL) of healthy human volunteers. While, 6 hours-post 
exposure, the bronchial biopsies of these donors showed increases in mast cells, 
neutrophils, CD4+ and CD8+ T lymphocytes, LFA-1+ cells, as well as ICAM-1 and VCAM-
1 cell adhesion molecules.46 In a follow up to this study, the same group used bronchial 
washes and endobronchial biopsies of acutely exposed healthy volunteers to demonstrate 
an upregulation in IL-8 and IL-5 gene expression, as well as an increase in growth regulated 
oncogene-alpha (GRO-) protein levels47. Furthermore, a study by Rouse et. al., has shown 
that in BALB/c mice, butadiene soot, which is derived from an incomplete combustion of 
1,3-butadiene, can cause the alveolar macrophages to be laden with particles, while 
                                                      
44 McCreanor et al., “Respiratory Effects of Exposure to Diesel Traffic in Persons with 
Asthma.” 
45 Totlandsdal et al., “The Occurrence of Polycyclic Aromatic Hydrocarbons and 
Their Derivatives and the Proinflammatory Potential of Fractionated Extracts of 
Diesel Exhaust and Wood Smoke Particles.” 
46 Salvi et al., “Acute Inflammatory Responses in the Airways and Peripheral Blood 
After Short-Term Exposure to Diesel Exhaust in Healthy Human Volunteers.” 
47 Salvi et al., “Acute Exposure to Diesel Exhaust Increases IL-8 and GRO- α 
Production in Healthy Human Airways.” 
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experiencing an increase in neutrophil infiltration of the airway, and an upregulation of IL-
6, C-X-C motif ligand 2 and 3 (CXCL-2 and CXCL-3), and granulocyte chemotactic 
protein (CXCL6), which are all pro-inflammatory factors48. This suggests an extensive 
effect of DEE exposure on airway inflammation that further sheds light on the changes that 
occur in the airway in association with DEE exposure, which could lead to a better 
understanding of its pathogenic qualities. 
Although it is important to note the presence and effects of the inflammatory 
response due to DEE exposure, it is equally as important to note that changes in the immune 
system due to DEE exposure may cause abnormal responses to other biological insults. 
Studies show that alveolar macrophages in healthy rats that have exposure to DEE or 
organic extracts of DEE are unable to properly clear Listeria monocytogenes infection due 
to attenuated phagocytosis and liquidation of the bacterial cells and modifies production of 
certain pro-inflammatory cytokines 49 . A recent in vitro study of primary bronchial 
epithelial cells (PBECs) obtained from COPD patients and grown in air-liquid interphase 
(ALI) cultures looked at molecular responses to non-typeable Haemophilus influenza 
(NTHi) after exposure to whole diesel exhaust. The results showed that, as predicted, whole 
diesel exhaust alone caused an upregulation of oxidative stress response gene heme 
oxygenase-1 (HMOX-1) as well as integrated stress response genes CHOP and GADD35. 
However, when the exposure was followed up with NTHi, GADD35 expression increased 
                                                      
48 Rouse et al., “Soot Nanoparticles Promote Biotransformation, Oxidative Stress, 
and Inflammation in Murine Lungs.” 
49 Yin et al., “Suppression of Phagocytic and Bactericidal Functions of Rat Alveolar 
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3-fold, while the antimicrobial peptide S100A7 and chaperone protein HSP5A/BiP, which 
are generally present in NTHi-infected cells, were inhibited50. These findings suggest that 
DEE exposure modifies the immune response, thus creating susceptibility to pathogens 
that, in combination, may cause significant stress and greater biological damage than they 
otherwise would have. 
 
DEE, Inflammation, and Cancer 
The immunological effects caused by chronic DEE exposure may also lead to a 
cancer outcome. As early as 1955, researchers have shown that particulate matter from 
DEE contains PAHs, which were already known to lead to tumorigenesis in experimental 
animals51. The ensuing investigations of DEE effects in animals, such as that conducted by 
Mauderly et. al.52 have clearly demonstrated the potential of chronic DEE exposure to lead 
to carcinogenic outcomes in the airway, which prompted the IARC to label DEE as a 
possible human carcinogen in 198953. At present time, there is a substantial amount of 
evidence that demonstrates a higher prevalence of lung cancer due to continuous DEE 
exposure. The evidence has even shown that DEE can lead to other types of cancer, such 
                                                      
50 Zarcone et al., “Diesel Exhaust Alters the Response of Cultured Primary Bronchial 
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Chronically by Inhalation.” 
53 International Agency for Research on Cancer, “IARC Monographs on the 
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as bladder cancer.54 A seminal cohort mortality study55, and its companion nested case-
control study 56  have shown a strong association between DEE exposure, respirable 
elemental carbon (REC) levels, and prevalence of lung cancer in 12,315 mine workers from 
8 US non-metal mining facilities. The duration of work in the mines, the location of work 
underground compared to above ground, and an increased amount of REC were all 
positively correlated with lung cancer. Interestingly, the presence of smoking and the 
exposure variables that were measured in the nested case-control study appeared to have a 
mitigating effect of one another when subjects were exposed to both smoking and DEE. 
Other studies that investigated railroad workers who worked on trains with diesel 
locomotives57, 58, 59, truck industry employees60, 61, 62, 63,  and potash miners64 have all 
demonstrated that after taking into consideration smoking status and employment history, 
DEE exposure causes an increased incidence in lung cancer. These studies were vital in 
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IARC’s classification of DEE as a carcinogen in 2012, and display the detrimental effects 
of this preventable exposure. 
However, since it became conclusive that DEE is a carcinogen, it has become 
important to understand the mechanisms by which it causes the disease. An important 
consideration in understanding carcinogenesis is the involvement of the immune system. 
Lung diseases that have inflammation-related etiology, such as COPD and emphysema 
have been shown to be at a higher risk of progressing to lung cancer65, 66, 67. Helicobacter 
pylori, a gastric infection that causes prolonged periods of inflammation has been known 
for quite some time to lead to gastric adenocarcinoma68. Prolonged inflammation in one 
location may also lead to tissue damage, which ultimately results in recruitment of stem 
cells from bone marrow that divide and repopulate the area of injury. Due to the continued 
inflammatory destruction of the local tissue, such as from a chronic infection or injury, 
there is a drive to sustain the recruitment of stem cells, which undergo many rounds of 
division and thus may acquire genetic alterations, a process described in gastric cancers, 
but true for other epithelial cancer types as well69. Studies by Beachy et. al. also described 
the involvement of local stem cells that are involved in tissue repair to lead to cancer due 
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to chronic inflammation70. Furthermore, markers of inflammation, surfactant protein D 
(SP-D) and Krebs von Lungren–6 (KL-6), have also been associated with a positive risk of 
development of lung cancer. These markers are secreted by type II alveolar cells, which 
increase in numbers due to lung injury, and are generally known to be present in lung 
diseases, such as COPD and interstitial lung disease (ILD) 71, signifying a connection 
between inflammation, lung cancer, and other pulmonary diseases. More recently, 
prolonged DEE exposure in an occupational setting has been shown to lead to increased 
levels of CD4+ T cells, CD8+ T cells, and B lymphocytes in circulating blood 72 . 
Additionally, stimulation of the immune response in the airway has been shown to allow 
the intrinsic expression of oxygen-sensing prolyl-hydroxylase enzymes in T cells to lead 
to a suppression of TH1 cells and an induction of regulatory T cells (Tregs). This effect 
was demonstrated to modulate the immune response and, in fact, promote infiltration and 
growth of tumorigenic cells in the airways73. Albeit this is still a developing area of 
research, these and previously mentioned findings suggest that there is an important 
relationship between the prolonged induction of the inflammatory response due to chronic 
DEE exposure and lung cancer pathogenesis. 
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Lung Cancer 
Since lung cancer is the leading cause of cancer deaths worldwide among both 
genders74, and as such, may be considered as one of the most impactful diseases of the 
airways, there is a crucial need to understand the disease. One of the reasons why lung 
cancer is responsible for so many negative terminal outcomes is the lack of distinct signs 
and symptoms until stage IIIB or IV. Currently, at this disease stage, 5-year survival rates 
in the non-small cell carcinoma type of lung cancer is predicted to be 5%, at best75. In the 
last several decades, X-rays, computer tomography (CT), advanced surgical procedures, 
and chemotherapeutic agents have aided in diagnosis and treatment, but have not made 
enough improvement on the survival rate. As early as 1950’s and 60’s, smoking has been 
closely associated with the onset of lung cancer, which was noted in a landmark publication 
by Richard Doll and Bradford Hill76 and a decade later by the US Surgeon General’s 
report 77 . About a quarter of all lung cancers occur in non-smokers, and have been 
associated with exposures to radon, second-hand smoke, air pollution, and asbestos, among 
others78. Interestingly enough, even though 85-90% of patients who are diagnosed with 
lung cancer are either current or former smokers, only about 10-20% of heavy smokers 
develop the disease79. This suggests that lung cancer is primarily a disease caused by 
continuous insults to the organ, which may also lead to other types of airway and lung 
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disorders. Thus, it is important to understand the mechanisms and the exposure amounts, 
as they may serve as predictors of disease onset and progression. As smoking rates and air 
pollution are increasing in the developing world, the lung cancer rates will continue to rise, 
leading to an increasing number of preventable morbidity and mortality. 
Just as there may be various causes of lung cancer, the disease itself presents in a 
variety of ways. The lungs and the airways are a complex organ system made up of various 
cellular subtypes that all operate together to perform a vital function of gas exchange. The 
most common type of lung cancer is non-small cell lung cancer (NSCLC), which includes 
adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, all of which make up 
about 80-85% of all cases. Of the non-small cell lung cancer subtypes, adenocarcinoma, 
which arises from mucus secreting cells in the airway, is the most common. It represents 
almost half of all incidences of lung cancer and is the most common diagnosis of lung 
cancer in non-smokers. Squamous cell carcinoma is a disease of the bronchial lining that 
occurs most frequently in smokers, and makes up about a quarter of all lung cancers. Large 
cell carcinoma also originates from the bronchial epithelial cells, but appears more 
undifferentiated compared to the other NSCLC subtypes. This lung cancer subtype occurs 
in about a tenth of all lung cancers, in predominantly smoking related cases, and is 
characterized by a rapid progression80, 81. The other lung cancer types are small cell lung 
cancer (SCLS) and lung carcinoid tumors, which are much less common and make up about 
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10-15% and 5% of all cases, respectively82. The small cell lung cancer is a common 
manifestation in heavy smokers and presents with rapidly dividing cells that express both 
epithelial and neuroendocrine markers83. Lung carcinoid tumors are also recognized to 
express neuroendocrine markers, and more information is still being gathered on these lung 
cancer subtypes84. Due to the complexity of the lungs and airways, combined with the 
diverse nature of cancer in the organ establishes this topic as one of the most intensely 
studied areas of biomedical research worldwide. 
To be better able to understand the heterogeneity and etiology of lung cancer, it is 
crucial to focus on the changes that take place in the affected tissues. Pathological events, 
such as pulmonary pre-neoplastic lesions, atypical adenomatous hyperplasia, bronchial 
squamous dysplasia and carcinoma in situ (CIS), as well as neuroendocrine cell hyperplasia 
are all associated with lung carcinogenesis85. Understanding these premalignant changes 
on a molecular level and how they result in a disease outcome can aid in better diagnoses, 
treatments, and prevention of lung cancer. Exposure to carcinogenic materials, such as 
cigarette smoke, has been shown to alter the gene expression of a large portion of the 
airway epithelium, establishing what is now known as the “airway field of injury” 
hypothesis86. This concept, thus, suggests that the molecular changes that occur due to 
harmful insults of smoking or air pollution can be detected not just in the deep portions of 
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the airway, but in the more proximal and easily accessible tissues, such as the nose. 
Furthermore, identifying genetic changes that take place in the airway due to lung cancer 
is already possible87, 88, and is in the process of becoming a vital diagnostic tool in the 
clinic. The genomic classifier formulated in these studies are based on genetic information 
obtained from the mainstem bronchus. Current research is able to show that gene 
expression in the nasal epithelium may also be able to yield the necessary information to 
detect and diagnose lung cancer89. Thus, the detection, unraveling, and comprehension of 
the disease-associated transcriptomic changes in the airway are emerging as the cutting-
edge development in understanding lung cancer pathogenesis. This medically viable 
scientific advance will allow for more reliable and effective diagnostic and preventative 
tools, as well as the identification of agents that may play a role in causing the disease. 
The molecular changes that occur in the various types of lung cancer provide an 
important clue to its pathogenesis. Smoking history is also a contributing factor to the type 
of genetic changes that take place in both SCLC and NSCLC. Some of the major molecular 
changes that occur in the majority of NSCLC subtypes are mutations in the TP53 gene, 
CDKN2a/RB pathway defects, loss of alleles containing genes FHIT, SEMA3B, and 
RASSF1A, which are located on the short arm of chromosome 3, as well as improper 
promoter methylation of O6MGMT, CDKN2a, DAPK, TIMP-3, or RASSF1A. In current 
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or former smokers who have NSCLC, mutations in KRAS appear more commonly, 
whereas for never smokers, mutations in EGFR predominate. Alterations in these two 
genes appear to be mutually exclusive, although mutations in the TP53 gene are concordant 
with both90. SCLC has similar characteristic molecular modifications. Just as in NSCLC, 
albeit more frequently, the loss of tumor suppressors FHIT and RB1, as well as mutations 
in TP53 are a common occurrence in this lung cancer type. Additionally, increased 
expression of MAD1 has been observed, while mutations in EGFR or KRAS are much less 
frequent91. SCLC also exhibits mutations in histone modifiers CREBBP, EP300, and MLL, 
as well as augmentation of oncogene FGFR192. Moreover, both of these lung cancer types 
undergo epigenetic alterations of the CpG islands in the tumor suppressor genes RB, p16, 
VHL, and APC 93 . As the picture suggests, lung cancer has its roots in a variety of 
dysregulated molecular mechanisms that function in the various parts of a complex airway 
system. 
As the major transcriptomic changes in lung cancer are slowly coming into light, it 
is important to consider how the expression of genes is altered due to exposures that have 
been shown to lead to the disease. Smoking has long been known as one of the most 
detrimental exposures for the airway. Cigarette smoke is made up of over 5,000 chemical 
compounds, some of which are of carcinogenic nature, including polycyclic aromatic 
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hydrocarbons (PAH) and nitrosamines94. The molecular responses that are caused due to 
cigarette smoke exposure have been extensively studied in our laboratory 95 , 96 , 97 . A 
common theme in these studies shows that airway exposure to cigarette smoke causes DNA 
damage, generation of reactive oxygen species (ROS), as well as an upregulation of the 
Nrf2 mediated-xenobiotic response and Aryl-hydrocarbon Receptor (AhR) pathway genes. 
Most notably, cytochrome P450 1B1 (CYP1B1) and CYP1A1 have been shown to have 
the highest upregulation among the genes that change in the airway due to smoking. 
Predictably, expression of miRNAs, such as miR-218 were also shown to be different 
between smokers and non-smokers98. Many of the differences between smokers and non-
smokers may even be detected in the nasal epithelium, as expected based on the “airway 
field of injury” hypothesis99, 100. Other exposures have also been demonstrated to cause 
transcriptomic changes. Household air pollution from smoky coal has been shown to lead 
to lung cancer101. In our studies, the gene expression changes in the buccal epithelium in 
women exposed to smoky coal have a marked induction of the inflammatory genes, such 
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as IL-8, as well as toll-like receptor (TLR) signaling and cytokine-cytokine interaction 
pathways, which are exemplary of toxic airway exposure102. Additionally, our lab has 
investigated new potential carcinogenic exposures, such as electronic cigarette (ECig) 
smoke. Similar to previous findings, ECig smoke exposure was shown to induce the 
upregulation of CYP1B1, CYP1A1, and ROS103. The work in our lab, thus shows that toxic 
airway exposures have a distinct transcriptomic effect that may very well be involved in 
causing diseases of the lung and airways. 
 
Transcriptomic Changes Associated with DEE Exposure 
Many of the molecular alterations that are involved in toxic airway exposure 
response have been elucidated, and it is now important to consider the response from DEE 
exposure and the mechanisms by which it causes disease. DEE exposure elicits a response 
in epithelial cells of the airway, primarily via the modulation of stress response genes. In 
the aforementioned study by Rouse et. al., butadiene soot has been shown to cause 
epithelial damage of the airway, as well as an upregulation of AhR repressor, cytochrome 
P-450 A1 and B1 (CYP1A1 and CYP1B1), and HMOX-1 in BALB/c mice 104 . In 
experiments by Chan et. al. with premixed flame particles (PFP), which are readily used as 
a substitute for DEE in experimental procedures and are rich in PAH’s, an increased 
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cellular toxicity in the airway along with an induction of a response to reactive oxygen 
species (ROS) has been demonstrated105, 106. Similar to the butadiene soot exposure, the 
group showed that in airways of rats, PFP also caused an upregulation of CYP1A1, 
CYP1B1, AhR, and other xenobiotic response element components 107. In a follow-up 
study, they also showed an upregulation of HMOX-1, a gene mediated by a transcription 
factor Nrf2, which was also upregulated108. Together, these results show a strong activation 
of a stress response by the DEE, which could explain some of the mechanisms involved in 
disease pathogenesis. However, even though there have been multiple studies performed 
assessing various possible effector mechanisms due to DEE exposure, none have 
performed high-throughput genomic studies of the airway in human subjects. 
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SPECIFIC AIMS 
Exploration of DEE exposure in the nose to understand lung cancer risk 
• Assess gene expression changes in the nasal epithelium due to DEE exposure of 
the airway 
• Investigate the differences in gene expression changes due to DEE exposure and 
due to smoking status, and compare the findings to other studies assessing airway 
exposures 
• Determine which molecular mechanisms are involved in the response to DEE 
exposure in the nasal epithelium and if these mechanisms may be involved in the 
development of an airway disease 
• Compare the changes in gene expression and molecular responses due to DEE 
exposure to that of other exposures in similar studies 
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METHODS 
 
Diesel Engine Exhaust Exposure 
 
Workers who were employed in a manufacturing company of diesel engines for 
light and heavy trucks were recruited into the exposed experimental group. The company 
manufactures 10,000 – 20,000 diesel engines each month. After the assembly and before 
any after-treatment systems are installed, the power output assessment, quality control, and 
tuning for every engine is performed using the diesel engine dynamometer in, what is 
referred to as, the “Dyno-room”. The 44 total Dyno-rooms in the diesel engine factory, 
which operate at 25-50% capacity, are open at the top and contain ventilation vents, 
allowing the exhaust to escape from the Dyno-rooms. Additionally, some of the exhaust 
from the engines is allowed to flow directly into the local exhaust system in the factory. 
From the 91 subjects, whose RNA was used for the microarray study, 47 male volunteers 
regularly performed most of their daily functions in the Dyno-rooms, in close proximity to 
the diesel engines that were tested, and were considered to be DEE exposed. After the 
quality control procedures (described below) reduced the number to 79 subjects, 41 male 
volunteers remained in the DEE exposed group. 
 
Control Exposure 
 Workers who were employed in facilities where diesel engine exhaust was not 
present were recruited into the control experimental group. In the sample set of 91 subjects, 
the control group consisted of 44 male volunteer subjects that were matched to the DEE 
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exposed volunteer subjects by age (within 5 years) and by smoking status (current, former, 
never). After the sample set was reduced to 79 subjects, 38 male volunteer subjects 
remained in the control group. The facilities from which volunteers were recruited are 
located in the same region of China as the diesel engine factory, and are listed as follows, 
“control factory 1” (n=6), “control factory 2” (n=8), “control factory 3” (n=21), “control 
factory 4” (n=3), and “control factory 5” (n=6). A detailed walk-through survey was 
performed to determine that none of these workplaces contained any sources that could 
produce DEE, or contained any other type of particulate matter, genotoxic, hematoxic, or 
immunotoxic compounds.  
 
Exposure Assessment 
 Personal cyclone air samplers attached to a lapel near the breathing zone were used 
at a flow rate of 3.5 L/min and an aerodynamic cut-off of 2.5 m (PM2.5) to obtain repeated 
full-shift personal air sample collections for determining exposure levels to various 
components of DEE. Elemental Carbon (EC) and Organic Carbon (OC) exposures were 
determined using the quartz-fiber filter and the NIOSH Method 5040 for collecting 
DPM 109 , 110 . Teflon filters were used to obtain PM2.5 measurements. Exposure 
concentrations in g/m3 were calculated by taking the weight measurements of EC, OC, 
and PM2.5 and dividing them by the volume of air drawn through the filter. Each filter was 
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weighed in duplicate pre and post exposure using a microbalance with a 1 g accuracy in 
an environmentally controlled weighing room. Duplicate measurements of the filter that 
differed by more than 5 g were reweighed. Reflectance values for the soot content were 
obtained using a smoke stain reflectometer (model M43D, diffusion Systems Ltd, London, 
UK) on both the quartz and Teflon filters, and the values were converted to obtain 
absorption coefficients, measured in 10-5/m. 
The four components of DEE exposure were measured in a subset of the control 
volunteer study subjects in factories 1, 2, and 5. The geometric mean was calculated for 
each DEE exposure component in each factory. The average and standard deviation of the 
geometric means for each exposure component across all factories was calculated and used 
as the definitive values for the control group. Average values of each DEE exposure 
component were also measured for the 47 exposed volunteers in the diesel factory. The 
values of each exposure variable for each control factory and the diesel factory can be seen 
in Table 1 below. 
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Table 1. Measurements of each exposure component in each factory. Geometric means 
were calculated for a group of volunteers in the three control factories from where 
measurements were obtained for each exposure. Averages and standard deviations of the 
geometric means were calculated for each exposure component measured in the control 
factories and in the diesel factory. 
Factory Measurement Geometric Mean AVERAGE STD 
1 
EC 
10.87 
11.11 1.35 2 9.89 
5 12.55 
Diesel   59.47 22.50 
1 
OC 
68.10 
68.73 4.07 2 65.00 
5 73.08 
Diesel   139.00 26.90 
1 
ABS 
6.72 
6.83 0.64 2 6.24 
5 7.52 
Diesel   50.61 15.10 
1 
PM2.5 
0.18 
0.22 0.07 2 0.19 
5 0.30 
Diesel   0.36 0.07 
 
Volunteer Subjects and Sample Collection 
 1-2 nasal brushing samples from one or both nostrils were obtained from 
112 healthy volunteer donor subjects that were either exposed to diesel engine exhaust or 
not exposed. Duplicate samples were collected from 6 volunteer subjects to make up a total 
of 118 brushing samples. Each brush that was used to gently scrape the nasal epithelium 
of the volunteer subjects were placed into individual tubes with 1 ml of RNAlater (Qiagen, 
Valencia, CA) immediately after sample collection. The participation in the study was 
voluntary for all donor subjects enrolled in the study, and written informed consent was 
formally obtained. The demographic data and nasal brushing sample collection was 
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performed by the local Center for Disease Control (CDC) in China during the 
administration of a regular health exam. This study was approved by the US National 
Cancer Institute (NCI), as well as by the National Institute of Occupational Health and 
Poison Control in the Chinese Center for Disease Control and Prevention (CDC). 
Collected samples of cells were stored at -80C, and total RNA was isolated at 
ambient room temperature using the miRNeasy Mini Kit (Qiagen, Valencia, CA). Samples 
that contained two nasal brushes were combined for the purpose of obtaining sufficient 
RNA for further analytic procedures. NanoDrop spectrophotometer was used to assess 
RNA purity, while the Agilent BioAnalyzer was used to determine RNA integrity (RIN) 
scores. For the 6 duplicate samples, the ones with the best RIN scores were used for further 
analysis. 94 samples with at least 200g of total RNA and sufficient quality for both 
microarray and sequencing studies were further analyzed.  
 
Microarray Processing 
100ng of RNA from each of the 94 samples was hybridized to Affymetrix Human 
Gene 1.0 ST GeneChips (Affymetrix, Santa Clara, CA) using the previously described 
Affymetrix protocols111. Samples were split into 2 batches, which maintained an even 
distribution of samples handled by each of the two technicians processing the RNA, as well 
as evenly matched RIN scores in both batches. CEL files were generated, and a custom 
Chip Definition File (CDF) containing 19,718 Entrez Gene identifiers 
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(hugene10stv1hsentrezgcdf and hugene10stv1hsentrezg.db packages) was utilized for the 
Robust Multiarray Average (RMA) array normalization and probe-level summarization112. 
Additionally, Affymetrix Expression Console software (version 1.4.1.46) was used to re-
normalize all of the arrays using the RMA procedure, detection above background 
(DABG), and the default Affymetrix probeset mappings in order to compute the Area 
Under the Receiver Operating Characteristics Curve (AUC). Expression of each gene on 
each array was log2 transformed to fit statistical assumptions in the ensuing analyses. 3 of 
the samples processed on microarrays were “QC” samples, which were collected during 
field training and used to assess quality of any future laboratory assay to be performed. 
One of the subjects from whom the QC sample was obtained, laterally enrolled into the 
study, and both of the samples were present in the sample set of 94 microarrays. The 
investigators performing the statistical analysis of the arrays were blinded to which samples 
originated from the QC subset of volunteer donor subjects until after the microarray 
experiment was completed. At this point the QC samples were excluded from the main 
statistical analysis, with 91 microarray samples remaining.  
 
Quality Control and Statistical Analyses 
Quality of the arrays was determined using Relative Log Expression (RLE), 
Normalized Unscaled Standard Error (NUSE), and the AUC values derived from the 
Affymetrix Expression Console software. Arrays were deemed to have good quality if they 
                                                      
112 Dai et al., “Evolving Gene/transcript Definitions Significantly Alter the 
Interpretation of GeneChip Data.” 
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had RLE values < 0.1, NUSE values < 1.05, and AUC values > 0.8. Based on the results 
of the quality analysis, 12 samples were deemed to have quality metric values that are 
outside the set thresholds, and thus ruled out from further statistical analyses. The 
remaining 79 samples were renormalized using the RMA algorithm with a custom CDF. 
Principal component analysis (PCA) was performed to obtain a qualitative visualization of 
samples based on the aspects that have the biggest contribution to gene expression changes. 
The method ranks the major components that contribute to variance in the experiment, with 
Principal Component 1 (PC1), contributing the most variance, PC2, the second most, and 
so on.  
Adjustment for any batch effects that may have occurred was made by executing 
the ComBat algorithm in the SVA package of the Bioconductor software. This requires the 
inclusion of Batch as a covariate term in any linear model that would be subsequently run. 
A linear modeling approach was used to assess how gene expression changes occur due to 
DEE exposure after adjusting for RIN, batch, and smoking status as covariates (~Diesel + 
RIN + Batch + Smoking) or due to smoking status, with RIN, batch, and DEE exposure as 
covariates (~Smoking + RIN + Batch + Diesel). Additionally, the linear modeling approach 
was used to explore the interaction effect between DEE exposure and smoking status, with 
RIN and batch as covariates (~Diesel + RIN + Batch + Smoking + Diesel:Smoking). P 
values, t-statistics, and Benjamini-Hochberg False Discovery Rate (FDR) q values were 
calculated for each gene in each linear model. The statistical analyses were performed 
 31 
using the R programming language (http://r-project.org) version 2.15.3 and packages from 
the Bioconductor software113.  
 
Enrichment and Pathway Analyses 
 Gene Set Enrichment Analysis (GSEA)114, 115 was used to explore the concordance 
of gene expression changes in our data set and a previously established list of 254 genes 
that change between current and never smokers. The initial list of 175 genes derived from 
a linear modeling approach was first described in the 2007 Beane et. al. Genome Biology 
article116, and the updates to the list, as well as the complete list of genes in the linear model 
ranked by t-statistic were kindly provided by Dr. Jennifer Beane. The genes from the linear 
models in our data assessing DEE exposure and smoking status were ranked based on their 
respective t-statistics. 
EnrichR 117  was used for further pathway analysis of the 225 genes that were 
differentially expressed in the ~Diesel + RIN + Batch + Smoking linear model. The test 
performs a Fisher exact test to determine if a gene belongs to a particular pathway gene 
set. This allows a better understanding of how the genes that belong to a particular pathway 
are related to other genes in that pathway, as well as how pertinent is the gene-set library 
to the rest of the genes. The genes were split into 133 upregulated and 92 downregulated 
                                                      
113 Gentleman et al., “Bioconductor.” 
114 Mootha et al., “PGC-1α-Responsive Genes Involved in Oxidative Phosphorylation 
Are Coordinately Downregulated in Human Diabetes.” 
115 Subramanian et al., “Gene Set Enrichment Analysis.” 
116 Beane et al., “Reversible and Permanent Effects of Tobacco Smoke Exposure on 
Airway Epithelial Gene Expression.” 
117 Chen et al., “Enrichr.” 
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features that were input into the browser based analysis algorithm, and the result tables 
from BioCarta (2016), KEGG (2016), WikiPathways (2016), GO Biological Process 
(2015), and GO Molecular Function (2015) were obtained. The pathway terms with p-
values < 0.05 were retained and organized by 1 gene, 2 genes, 3 genes, and 4+ genes being 
present in the corresponding term’s gene set. Terms with at least 3 genes were categorized, 
grouped, and tabulated based on the number of times the term occurs across the five 
databases. Terms that belong to only one category were grouped together and titled “One 
category”. A list of Upregulated and Downregulated pathway categories was formulated 
to suggest the most likely processes that may be occurring as a result of DEE exposure. 
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RESULTS 
Quality Control of Microarray Results  
Normalization was performed for 91 samples, and RLE, NUSE, as well as AUC 
quality metrics were used to remove 12 samples that did not pass at least two of these 
metrics. The resulting 79 samples were renormalized together, and PCAs of both 
normalizations across all 19,718 genes were constructed for a qualitative visualization of 
the variance in the experiment. The PCA of all 91 samples, seen in Figure 1A, shows 
several of the samples from the group that was adjudged to have poor quality separating 
from the main group of samples along the PC1 axis, which is responsible for 48% of all 
variance in the experiment. Figure 1B shows a PCA of the 79 samples having less 
separation than did the 91 samples along the PC1 axis. In Figure 1B, the PC1 axis is 
responsible for 41% of all variance, after the removal of the samples with poor quality. 
 
Figure 1. PCA across all genes of 91 and 79 samples. PCA of 91 samples (A) shows a 
clear separation of a small number of samples from the main group along the PC1 axis, 
confirming these samples as outliers. After the removal of the outliers, the PCA of the 
resulting 79 samples (B) has 7% less variance along the PC1 axis. 
  
A
.
B
.
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Demographic and Exposure Information of the 79 Volunteer Donors  
After the quality control analysis of the microarray experiment, 79 samples were 
selected as the final list to be analyzed further. Table 2 below describes the information 
collected during the health exam of these 79 volunteers, with 38 controls and 41 DEE 
exposed. The subjects in each group were well matched based on age, BMI, current 
smoking status and recent infection status. Table 3 shows the means and standard 
deviations of the data obtained for each exposure component in the exposed and control 
groups. The means recorded for the control group represent the averages of the geometric 
means from the three control factories where measurements were obtained, and are 
recorded as the Unadjusted values. The Unadjusted values of the DEE exposed group are 
comprised of the means of all of the recorded values for that particular exposure component 
in that group. The Background Adjusted values represent the Unadjusted values after 
subtracting the control Unadjusted values. 
Table 2. Demographic, smoking data of the 79 volunteer donor subjects whose 
microarray were retained for statistical analysis. Means, standard deviations, and p-
values from the Wilcoxon test (*) between the exposed and control groups were calculated 
for age, BMI and work years in factory. The number of subjects and percent in the 
respective exposure group are shown for each smoking status and for self-reported recent 
infection. Fisher’s Exact Test (✝) was performed for each smoking status and for the 
determination of a recent infection between control and exposed groups. 
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Subjects (n=79) Control (n=38) Exposed (n=41) P-values 
Age, mean (SD) 41.3, (6.7) 41.0, (6.9) 0.95* 
BMI, mean (SD) 25.1, (4.1) 24.6, (3.1) 0.78* 
Work years in factory, mean (SD) 12.8, (8.1) 18.5, (7.0) 0.002* 
Smoking Status       
Current, n (%) 24, (63.2) 23, (56.1) 0.65✝ 
Former, n (%) 9, (23.7) 10, (24.4) 1✝ 
Never, n (%) 5, (13.2) 8, (19.5) 0.55✝ 
Recent Infection       
Yes, n (%) 19, (50.0) 19, (46.3) 0.82✝ 
No, n (%) 19, (50.0) 22, (53.7)   
 
Table 3. Means and standard deviations for each exposure component in the control 
and DEE exposed groups. Elemental and Organic Carbon were measured in g/m3, while 
PM2.5 was measured in mg/m3. Soot values were converted to absorption coefficients 
measured in 10-5/m units. 
Subjects (n=79) 
Control (n=38) Exposed (n=41) 
Mean SD Mean SD 
Elemental Carbon, g/m3         
Background Adjusted 0 
1.34 
46.44 
20.87 
Unadjusted 11.10 57.54 
Organic Carbon, g/m3         
Background Adjusted 0 
4.03 
67.96 
25.39 
Unadjusted 68.70 136.66 
Soot (absorption coefficient in 10-5/m)         
Background Adjusted 0 
0.64 
42.74 
14.40 
Unadjusted 6.80 49.57 
PM2.5, mg/m3         
Background Adjusted 0 
0.07 
0.14 
0.07 
Unadjusted 0.20 0.36 
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ComBat Batch Correction 
The ComBat batch correction algorithm was used to account for any batch effects 
that may have occurred due to the microarrays being run in two batches. PCAs were 
constructed to visualize all 79 samples in the two batches before and after the algorithm 
was executed (Pre-ComBat and Post-ComBat, respectively), for all genes and for only the 
1,133 genes that are differentially expressed between the two batches at p < 0.05 in a 
Student’s t-test between batches. The plots show a reduction in variance that is caused by 
the batch effects, and, as expected, is most visible in the genes that are differentially 
expressed between batches. The reduction of % variance occurs for both PC1 and PC2, and 
is accompanied by a reduction of differentially expressed genes between batches to 139 at 
p < 0.05 in the Student’s t test. The PCA plots of the analysis can be seen in Figure 2 below. 
 
A B 
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Figure 2. PCA of all 79 samples before and after batch correction across all genes or 
across only 1,133 differentially expressed genes. The samples were colored yellow or 
blue based on the batch which they were in. Both Pre-ComBat (A) and Post-ComBat (B) 
PCA plots maintain the same level of variance along both PC1 and PC2 axes. The 1,133 
genes with p < 0.05 between the two batches show separation along the PC1 and PC2 axes 
before ComBat (C), and marginally decreased separation along both axes after ComBat 
(D). 
 
Assessment of Major Influences on Gene Expression 
PCA analysis was further used to determine components that could be causing the 
greatest changes in gene expression of the raw data across all genes in the 79 samples. 
PCAs were colored by levels of Elemental Carbon, Organic Carbon, Soot, PM2.5 (data not 
shown), as well as for DEE exposure, smoking status, and RIN (Figure 3). The coloring of 
the PCA plot based on the available information on the data showed that RIN is the largest 
contributor to the variance in the experiment, as it was the metric with the clearest 
separation along the PC1 axis. A Pearson correlation plot of the PC1 and RIN was 
constructed with a correlation r-value being 0.79, suggesting a positive correlation. 
C D 
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Figure 3. PCA plots colored by exposure variables and a Pearson correlation plot of 
PC1 vs RIN. Both the DEE exposure and the smoking status did not appear to cause a 
visible separation between any of their respective groups neither along the PC1 nor along 
the PC2 axes. DEE exposure is shown in orange, and control is in gray (A). Current 
smokers are colored in orange, former smokers in yellow, and never smokers in gray (B). 
The quality of the RNA, represented by the RIN scores, appears to have the strongest 
contribution to gene expression (C). Samples with RIN scores in the 7.1-9 range are shown 
in blue and appear to separate along the PC1 axis from the samples with RIN scores in the 
5.1-7 range, shown in green. Both groups further separate along the PC1 axis from the 
samples with low RIN scores that appear in yellow and red. The Pearson correlation plot 
of PC1 vs RIN shows a strong positive correlation between them of 0.79 (D). 
A 
Diesel 
Control 
B 
Current 
Former 
Never 
C 
7.1-9 
5.1-7 
3.1-5 
< 3 
r = 0.79 
D 
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 The results indicate that quality of the RNA introduces a technical effect that is 
important to consider when assessing differential expression between experimental groups.  
 
Smoking Exposure 
Our lab’s previous analyses of differential expression due to smoking have yielded 
a list of genes that change between current smokers and a combination of both former and 
never smokers, that is summarized in the Beane et. al. Genome Biology (GB) publication. 
Thus, it was important for us to maintain this comparison as a matter of best scientific 
practices. We set out to understand if there were also significant gene expression 
differences between the former and never smoker groups. A linear modelling approach 
assessed the number of genes differentially expressed in the comparison between current 
smokers and combined former/never smokers after adjustments for RIN, Batch, and DEE 
exposure (~Current Smoker + RIN + Batch + Diesel). A linear model was also constructed 
to assess the categorical differences between all three smoking status groups with the same 
covariate adjustments (~All Smoking Groups + RIN + Batch + Diesel). It is important to 
note that there were more samples derived from current smokers than from former and 
never smokers combined in both the DEE exposed and control groups. The number of 
genes that are differentially expressed at various p and FDR q value cutoffs for both linear 
models is shown below in Table 4. The “Current Smoker” linear model yielded more genes 
that differ between current smokers and former/never smokers at various cutoffs, than the 
“All Smoking Groups” model assessing genes that change between all three groups. 
Additionally, a heatmap of the 726 genes that are differentially expressed at FDR q < 0.25 
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in the linear model assessing “All Smoking Groups” was constructed to understand how 
closely each group is related (Figure 4). The current smokers cluster primarily together on 
the right side of the heatmap, while the former and never smokers cluster separately on the 
left side of the heatmap. 
Table 4. Number of genes differentially expressed at various p-value and FDR q-value 
cutoffs in the smoking-related linear models. The linear model in the left column 
displays the number of differentially expressed genes at various cutoffs associated with the 
comparison between current smokers and the combined former and never smoker groups. 
The right column shows the number of differentially expressed genes at the same cutoffs 
as before that are associated with the comparison between all three smoking status groups. 
 
79 samples 
All genes in our data set 
~Current Smoker + 
RIN + batch + Diesel 
~All Smoking Groups + 
RIN + batch + Diesel 
p < 0.05 2769 2273 
FDR q < 0.25 1591 726 
FDR q < 0.05 318 147 
 
 
Current 
Smokers 
Former 
Smokers 
Never 
Smokers 
Diesel 
Control 
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Figure 4. Heatmap of the 726 genes differentially expressed at FDR q < 0.25 due to 
smoking status. In the top color bar, dark green represents current smokers, clustering 
together primarily on the right. The light green represents former smokers and yellow 
represents never smokers. These two groups cluster on the left with similar patterns of 
differential expression. 
 
Furthermore, Student t tests were run on all three individual smoking group 
comparisons, as well as on the current vs former/never comparison. Based on the t-tests, 
shown in Table 5, the differences in gene expression appear to be the greatest between 
current smokers and never smokers, with the differences between current smokers and 
former smokers being a lot smaller. However, the number of genes differentially expressed 
between former and never smokers is around what is expected by chance (986 genes). The 
t-test between current smokers and both former and never smokers had a lot more genes 
differentially expressed after performing the Benjamini-Hochberg False Discovery Rate 
test at both noted q-value cutoffs. The analysis noted difference between the two 
approaches and allowed the “Current Smoker” linear model to be used for direct 
comparisons with the GB genes.  
Table 5. Number of genes differentially expressed at various p-value and FDR q-value 
cutoffs in the Student’s t-tests between various smoking groups. 
 
Student t-tests, 79 samples, Post-ComBat 
Current vs 
Former 
Current vs 
Never 
Former vs 
Never 
Current vs 
Former/Never 
p < 0.05 1643 5318 945 3777 
FDR q < 0.25 291 252 0 3461 
FDR q < 0.05 49 134 0 429 
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Moreover, the list of 254 genes from the GB dataset that change due to smoking 
were observed in our dataset. Table 6 below shows that a substantial number of the genes 
from the GB dataset are differentially expressed below various thresholds in the “Current 
Smoker” linear model.  
Table 6. Number of GB genes differentially expressed at various p-value and FDR q-
value cutoffs in the “Current Smoking” linear model. 
  
79 samples 
Genome Biology genes in our data set 
~Current Smoker + RIN + batch + Diesel 
p < 0.05 99 
FDR q < 0.25 148 
FDR q < 0.05 66 
 
GSEA was then used to project the up and down-regulated genes from the list of 
254 GB genes into the list of all genes in the “Current Smoking” linear model ranked by t-
statistic. Both the up and down-regulated GB genes have a significant enrichment in our 
dataset. The reverse analysis of projecting the 318 genes from our “Current Smoking” 
linear model into the ranked list of all GB genes yielded similarly significant results 
displaying the same pattern as can be seen in Figure 5 below. 
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Figure 5. Normalized Enrichment Scores (NES) of the GSEA projecting the GB genes 
into the “Current Smoker” linear model, and the significant differentially expressed 
genes from the model into the GB gene set. GB up and GB down genes are the up and 
down- regulated genes in the GB dataset, respectively. Smoking up and Smoking down 
genes are the up and down-regulated genes in the “Current Smoking” linear model. The 
up-regulated genes are shown in red and the down-regulated genes are shown in blue. The 
FDR q value of every enrichment in the plot was <0.001 as indicated by *. 
 
 
 
Diesel Engine Exhaust Exposure 
After confirming the correlation between the genes that change due to smoking in 
our dataset and in the previously scrutinized dataset, genes that change due to DEE 
exposure were assessed. A linear modelling approach was used once again to show the 
genes that change due to DEE exposure, after adjusting for RIN, Batch, and “Current 
Smoker” (~Diesel + RIN + Batch + Current Smoker). Table 7 below shows the number of 
genes differentially expressed at various p and FDR q value cutoffs and Figure 6 shows a 
heatmap of the 225 genes that are differentially expressed at FDR q < 0.25. The two 
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clustering patterns in the heatmap are designated with the vertical color bars on the left of 
the heatmap. 
Table 7. Number of genes differentially expressed at various p-value and FDR q-value 
cutoffs in the DEE linear model. 
  
79 samples 
All genes in our data set 
~Diesel + RIN + batch + Current Smoker 
p < 0.05 1869 
FDR q < 0.25 225 
FDR q < 0.05 4 
 
 
Figure 6. Heatmap of the 225 genes differentially expressed at FDR q < 0.25 due to 
DEE exposure. In the top color bar, the increase in Elemental Carbon exposure is 
represented with a progression from light to dark gray. In the middle bar, as before, the 
dark green represents current smokers, the light green represents former smokers, and 
yellow represents never smokers. There are two clusters, indicated by the vertical color 
bars on the left (blue and purple), each with a distinct pattern of differential expression. 
 
expression level
z-score
-2 +2
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EnrichR pathway analysis was performed with the 225 genes differentially 
expressed in the DEE linear model to investigate the mechanisms that may be affected by 
exposure to DEE. Terms with p < 0.05 and at least 3 representative genes in the input gene 
set were categorized and the number of terms in each category added together and tabulated 
in the lists of Upregulated or Downregulated pathways (Table 8). The analysis looks to 
highlight the possible cellular mechanisms that are most active in the response to DEE 
exposure. The most up-regulated pathway categories in the analysis involve cell cycle 
regulation as well as transcriptional processing and regulation. Protein modification, 
degradation, and synthesis were also highly enriched in this gene set. Furthermore, pathway 
categories that indicate damage to the cell or to the nucleic acid, as well as a response to 
oxidative stress or some external stimuli appeared to be involved as well. Interestingly, in 
the down-regulated pathway categories, there were terms that are involved in membrane 
transport, lipid modification, as well as transferase and ATPase activity. The Cystic 
Fibrosis Transmembrane Conductance Regulator (CFTR) gene responsible for the 
transmembrane chlorine channel was exceedingly present among many of the 
downregulated terms (data not shown). 
Table 8. A list of Up and Down-regulated pathway categories and the total 
number of representative terms from the EnrichR analysis. The left column of 
each table represents the pathway categories which summarize common terms. The 
right column represents the number of terms in each category that contain at least 3 
genes.
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Upregulated 
Pathways Total # of terms 
Cell Cycle & Division 39 
Transcription & RNA processing 18 
Protein Modification 12 
Protein Degradation 10 
Circadian Rhythm 9 
DNA repair 8 
DNA structure 8 
Response to external stimulus 7 
DNA replication 6 
Cell signalling 6 
RNA Degradation 5 
Oxidative Stress 5 
Gametogenesis 4 
Nucleotide Metabolism 4 
Notch 4 
Apoptosis 3 
Response to light stimulus 3 
p53 3 
Protein Synthesis 3 
EGFR 2 
Infection 2 
mTOR Signalling 2 
Hormones 2 
Inflammation 2 
Regulation of Binding  2 
One category 7 
 
Downregulated 
Pathways Total # of terms 
Transport 8 
Lipid modification 3 
Transferase Activity 3 
ATPase activity 2 
Ras signalling 2 
One category 4 
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The relationship between DEE and smoking in altering gene expression in 
the nasal epithelium was also assessed. GSEA was used to project the 254 GB 
smoking genes into the full list of genes from the DEE linear model, ranked by t-
statistic. Conversely, the 225 genes differentially expressed due to DEE exposure, as 
determined by the DEE linear model, were projected into the ranked list of all genes 
from the GB dataset. The results, presented in Figure 7 below, indicate a significant 
concordance between the up-regulated genes in both datasets. However, the down-
regulated genes from either gene set do not appear to be significantly enriched in 
the corresponding ranked list. Thus, it appears that both DEE and smoking causes 
an up-regulation of similar genes, but a downregulation of differing genes. 
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Figure 7. Normalized Enrichment Scores (NES) of the GSEA projecting the GB 
genes into the DEE linear model, and the significant differentially expressed 
genes from the model into the GB gene set. GB up and GB down genes are the up 
and down- regulated genes in the GB dataset, respectively. DEE up and DEE down 
genes are the up and down-regulated genes in the DEE linear model. The up-
regulated genes are shown in red and the down-regulated genes are shown in blue. 
The FDR q values of the GB up and GB down enrichments in the DEE ranked list 
were 0.16 and 0.77, respectively. The FDR q values of the DEE up and DEE down 
enrichments in the GB ranked list were <0.001 and 0.42 respectively. FDR q value 
below 0.001 is indicated with *. 
 
 
 
DEE and Smoking 
The relationship between the effects of DEE exposure and smoking on gene 
expression was investigated with a linear model that includes an interaction term 
for DEE and smoking. The results, shown in Table 9, revealed 8 genes at FDR q < 
0.25 that may be strongly altered by either the DEE exposure in current smokers or 
former/never smokers, or are altered by smoking status in either the DEE exposed 
or the control groups. Boxplots of these 8 genes (Figure 8) display how smoking and 
DEE exposure both influence their expression. Current smokers from both DEE 
exposed and control groups have similar patterns of expression for each one of 
these genes. For genes CYP1B1 and CYP1A1, it appears that smoking has a greater 
effect on expression. The opposite is true for CREBRF. The 4 genes with a negative t-
statistic (HYAL2, ESRP2, HOMEZ, and FKBP4) have log2 expression values that are 
more negative in the DEE exposed group than in any other group. 
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Table 9. Number of genes differentially expressed at various p-value and FDR q-value 
cutoffs in the DEE:Current Smoker interaction linear model. 
  
79 samples 
All genes in our data set 
~Diesel + RIN + batch + Current Smoker + Diesel:Current Smoker 
p < 0.05 1001 
FDR q < 0.25 8 
FDR q < 0.05 0 
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Figure 8. Boxplots of the 8 genes with FDR q values < 0.25 in the DEE and 
smoking interaction model. Boxplots are arranged from left to right in a decreasing 
order of magnitude of the t-statistic of the interaction term. The boxes in each plot 
are arranged from left to right in the following order: control and former/never 
smokers (control 0, salmon), control and current smokers (control 1, green), DEE 
exposed and former/never smokers (Diesel 0, blue), and DEE exposed and current 
smokers (Diesel 1, purple). 
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DISCUSSION 
 
 It has been known for decades that both acute and chronic DEE exposure plays an 
important role in exacerbating and even causing various diseases, primarily in the airway. 
The physiological effects of DEE exposure and its close association to lung cancer, 
demonstrated in various studies, has allowed the IARC to designate DEE as a carcinogen 
in 2012. However, there are still many questions about the mechanisms by which DEE 
causes airway disease, and especially cancer.  
In our study, we explored the transcriptomic effects of prolonged DEE exposure on 
the airway epithelium of factory workers who were chronically exposed to diesel engine 
exhaust in the workplace. More specifically, the study involved investigating how DEE 
alters the transcription of various genes in the nasal epithelium. As the “airway field of 
injury” hypothesis suggests, the nose can act as a surrogate for the rest of the airway in 
providing information about the transcriptomic changes that occur due to DEE exposure. 
This allowed an opportunity to collect data in a minimally invasive and efficient way that 
could shed some light on the mechanisms that, if functioning improperly, could be 
responsible for a disease outcome.  
Our previous findings provide an insight into the transcriptomic changes that occur 
due to smoking, and the data we obtained in this experiment corroborates those results. 
More than half of the genes that were found to be differentially expressed due to smoking 
in the Genome Biology article by Beane. et. al., were found to be differentially expressed 
in our data in the smoking linear model after adjusting for RIN, Batch, and DEE. 
Furthermore, we used GSEA to confirm that the genes that are both up and down-regulated 
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due to smoking in both datasets are significantly correlated with the up and down-regulated 
genes of the opposite gene lists that were ranked by their respective t-statistics. These 
findings confirm that the linear modeling approach that we used is properly able to predict 
differential expression of genes due to a particular exposure, as well as to differentiate the 
genes that change their expression due to smoking from those that change their expression 
due to DEE exposure. 
The linear modeling approach also yielded a list of 225 genes that have significantly 
altered expression patterns at FDR q < 0.25 as a result of DEE exposure. This list includes 
the Nuclear Factor, Erythroid 2 Like 2 (NFE2L2) gene, also known as Nrf2, CYP1B1, 
Oxidative Stress Induced Growth Inhibitor Family Member 2 (OSGIN2), and Hypoxia 
Inducible Factor-1 (HIF1A). These genes are generally involved in xenobiotic 
metabolism and oxidative stress response as a reaction to airway exposures to carcinogenic 
materials in DEE, such as benzo[a]pyrene or other polycyclic aromatic hydrocarbons. 
Additionally, these genes are known to be upregulated due to DEE exposure, as was the 
case in our linear modelling data, and have been shown to be upregulated in lung cancer. 
Thus, these findings suggest that an upregulation of mechanisms responsible for dealing 
with various components of DEE is similar to that when the airways are exposed to 
cigarette smoke.  
Furthermore, the linear model shows a downregulation of Platelet Activating Factor 
Acetylhydrolase 2 (PAFAH2) and Inhibitor of Nuclear Factor Kappa B Kinase Subunit 
Epsilon (IKBKE). These two genes are involved in inhibiting the immune response, and 
are themselves inhibited as a result of DEE exposure in our dataset. Additionally, some of 
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the upregulated genes, such as Mitogen-Activated Protein Kinase Kinase Kinase 2 
(MAP3K2), C-Type Lectin Domain Family 2 Member B (CLEC2B), and TANK-Binding 
Kinase 1 (TBK1), have been shown to be involved in a pro-inflammatory molecular 
response. Thus, it appears that there may be an inflammatory response that is activated 
when the nasal epithelium is exposed to DEE.  
Interestingly, there is a downregulation of genes and pathways that are involved in 
transmembrane transport. Some of these genes experiencing this behavior include CFTR, 
Calcium Voltage-Gated Channel Auxiliary Subunit Beta 3 (CACNB3), ATPase H+ 
Transporting Accessory Protein 1 Like (ATP6AP1L), ATPase phospholipid Transporting 
10B (ATP10B), and four Solute Carrier Family member genes, SLC16A13, SLC22A23, 
SLC26A6, and SLC35E2B, and are involved in movement of ions and solutes across the 
cellular membrane. The endocytosis related genes Hook Microtubule Tethering Protein 2 
(HOOK2) and Kringle Containing Transmembrane Protein 2 (KREMEN2) are also 
downregulated in the DEE linear model. Deposition of DEPs inside the nasal epithelial 
cells, and in the intracellular spaces has been shown using Transmission Electron 
Microscopy118. Thus, it is possible that the exposure of the nasal epithelial cells to DEE 
leads to a negative feedback where, either due to physical stress, oxidative stress, or DNA 
and protein damage, the cellular response is to prevent any more intake of the harmful 
compounds. 
                                                      
118 Boland et al., “Diesel Exhaust Particles Are Taken up by Human Airway Epithelial 
Cells in Vitro and Alter Cytokine Production.” 
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The EnrichR pathway analysis added further insight to the information that was 
obtained from a review of genes that were either up or downregulated in the DEE linear 
model. The pathway terms that appeared the most in the upregulated list indicate that 
regulation of the cell cycle and cell division were the primary effects of DEE exposure. 
This could be related to the DNA replication and DNA structure associated pathways, 
which appear closer to the top of the list. The pathway analysis also showed that there is a 
clear pressure that DEE particles impose on the cells. DNA repair, oxidative stress 
response, and response to external stimuli pathways are all well represented in the 
upregulated list. When combined with protein modification and degradation, as well as the 
upregulation of transcriptional and translational activity, it is possible to interpret this as a 
cellular response to stress from DEE particulate matter that is formulated via the production 
and modification of proteins that can metabolize the source of this pressure. 
 After a close analysis of the effects of DEE exposure on the nasal epithelium, it was 
important to consider how gene expression changes due to DEE were different from those 
caused by smoking. The GSEA approach was used to project the smoking-related genes 
from the GB article into the ranked list of genes by t-statistics from the DEE linear model 
and vice-versa, similarly to what was done previously with the “Current Smoker” linear 
model. The normalized enrichment scores for the upregulated genes in both projections 
were high, with significantly low FDR q values. However, the downregulated genes had 
low normalized enrichment scores in both comparisons with no statistical significance. The 
results suggest that there were similarities in the upregulated genes due to both smoking 
and DEE. On the other hand, the lower values of the NES scores in this analysis, as 
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compared to the GSEA analysis of the “Current Smoking” genes and the GB genes 
signifies that those similarities are limited. The discordance between the downregulated 
genes due to smoking and DEE is more striking. There is no significant enrichment of DEE 
genes in GB ranked list or of the GB smoking-related genes in the DEE ranked list. 
Therefore, it is possible to conclude that the effects on molecular mechanisms caused by 
DEE exposure have unique attributes, while also having some similarities to the molecular 
effects that are altered by smoking.  
 Since more than half of the enrolled study subjects were current smokers, an 
interaction model between smoking status and DEE exposure status was used to explore 
both of their contributions together. 8 genes with FDR q values < 0.25 were found to have 
significantly altered gene expression due to either smoking status, DEE exposure, or both, 
with an even number of genes having positive and negative t-statistics. In samples derived 
from DEE exposed donors who were either former or never smokers, the log2 expression 
values differed significantly from those in non-exposed control donors who were either 
former or never smokers. These findings confirm that DEE exposure by itself has an effect 
on gene expression. However, the boxplots showed that for the current smokers both with 
and without DEE exposure there was no significant difference in any of the 8 genes. This 
provides an interesting conundrum as it would be expected that the exposure to both 
smoking and DEE would either cause a distinct effect, or perhaps an additive effect. What 
is more interesting is that in 6 out of the 8 genes, the log2 expression is different between 
DEE exposed former/never smokers and either of the current smoker groups. This further 
 57 
confirms that the effects of smoking and DEE on gene expression may have similar trends 
but do observe differing behaviors.  
 When scrutinizing these 8 genes more closely, other subtleties become clear. In the 
CYP1B1 and CYP1A1 genes, smoking alone causes a significantly high upregulation of 
gene expression, while DEE exposure causes a smaller upregulation. Nevertheless, the 
combination of DEE and smoking raises the expression of these two genes to the level 
found in current smokers who were not exposed to DEE. This suggests that smoking may 
have a dominant effect in altering the expression of these genes, and may even saturate the 
AhR pathway to a point where DEE can no longer cause any changes. More peculiarly, a 
similar trend is seen in CREBRF. But in this case, smoking doesn’t cause an upregulation 
of this gene, whereas DEE exposure does. However, when looking at the expression of 
CREBRF in smokers who were exposed to DEE, the expression returns back to control 
levels. It appears almost as though smoking exposure prevents the upregulation of this gene 
by DEE exposure. Similarly, when looking at the four genes with negative t-statistics, it 
appears that DEE exposure alone causes a downregulation of these genes, while smoking 
alone doesn’t have an effect and even prevents any effect from occurring when combined 
with DEE exposure. The only exception is the HOMEZ gene, which has a significantly 
lower expression than the former/never smoker controls, but not as low of the expression 
levels as is caused by DEE in the former/never smokers. Thus, there is some sort of a 
preventative effect that occurs due to smoking. This also corroborates the findings that the 
downregulation of genes caused by DEE and by smoking differs in nature. Further still, the 
gene MAP3K8 has log2 expression levels of the three groups that received smoking 
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exposure, DEE exposure or both higher than in the unexposed former/never smoker 
controls, but similar for all three groups. This verifies the findings that some of the genes 
that are affected by smoking are also equally as affected by DEE.  
 
Conclusions  
 To the best of our knowledge, this is the first study that examines the complete 
transcriptome of the nasal epithelium in humans who experience chronic diesel engine 
exhaust exposure. It is clear from our findings that there are very distinct changes in gene 
expression that occur due to DEE exposure, which may be attenuated by and could 
completely differ from the effects of smoking. Additionally, DEE and smoking may be 
responsible for turning on some of the same mechanisms, such as the AhR pathway or the 
Nrf2-mediated xenobiotic metabolism, which could explain previous findings that DEE 
causes lung cancer and other diseases of the airway. It is also possible that DEE exposure 
leads to an inflammatory response that plays an important role in clearing the diesel exhaust 
particular matter, but has also been shown to be upregulated in various disease conditions 
in the airway.  
 
Study Limitations 
One of the limitations of this study is that it was only performed in males. A recent 
study on the deposition of ultrafine particulate matter (UPM) in the airways has shown that 
women experience a greater deposition of particles <0.1m, leading to a higher incidence 
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of adverse pulmonary effects than occurs in men after exposure119. The effects of DEE 
exposure experienced by children may also be different, where a preferentially allergic or 
chronic disease outcome may be more likely.  
Another limitation of this study may be the lack of information on whether the 
volunteer donors go on to develop any type of airway disease. This could allow 
investigators to relate airway exposure to DEE to an actual disease outcome. 
It would have also been helpful for proper linear modeling to have individual 
measurements of the four exposure components for all of the control samples. 
 
Future Steps 
• Use the Ingenuity Pathway Analysis (IPA) or GSEA with the Molecular Signature 
Database (MSigDB) to perform a validation of the pathway analysis of the 225 
genes differentially expressed in the DEE linear model to detect molecular 
mechanisms that are altered due to DEE exposure 
• Use the linear modeling approach to examine the transcriptomic effects in the 
airway due to the four measured exposure components (i.e. Elemental Carbon, 
Organic Carbon, PM2.5, and Soot) 
• Consider adjustment of the linear models for age, BMI, factory work years, and 
recent infection status as covariates 
                                                      
119 Sturm, “Total Deposition of Ultrafine Particles in the Lungs of Healthy Men and 
Women.” 
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• Determine if Elemental Carbon exposure levels can be used as a surrogate to assess 
dose dependent DEE exposure effects on the airway transcriptome 
• Compare the results of this analysis to other datasets that examine airway exposure 
to pollutants, such as the Smoky Coal dataset from the 2015 Carcinogenesis article 
by Wang et. al. 
• Perform miRNA-sequencing analysis of the samples to understand how the 
expression of miRNAs and their targets is altered due to DEE exposure 
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